(Alliance News) - The following London-listed shares received analyst recommendations on Wednesday morning and on Tuesday:

----------

FTSE 100

----------

Exane BNP raises Spirax to 'outperform' (neutral) - price target 8,350 (7,500) pence

----------

Keefe Bruyette & Woods raises Standard Chartered to 'market perform'

----------

JPMorgan raises Standard Chartered target to 2,220 (2,200) pence - 'overweight'

----------

Shore Capital raises HSBC to 'hold' (sell)

----------

Goldman Sachs raises HSBC price target to 1,700 (1,650) pence - 'buy'

----------

Jefferies cuts NatWest price target to 730 (750) pence - 'buy'

----------

Jefferies raises Barclays price target to 590 (570) pence - 'buy'

----------

Barclays raises Standard Life price target to 690 (660) pence - 'underweight'

----------

Deutsche Bank Research cuts Whitbread price target to 2,530 (2,815) pence - 'hold'

----------

Citigroup cuts GSK price target to 2,100 (2,250) pence - 'neutral'

----------

Bernstein cuts Informa price target to 1,033 (1,060) pence - 'outperform'

----------

Goldman Sachs raises United Utilities price target to 1,523 (1,346) pence - 'neutral'

----------

Goldman Sachs raises Pearson price target to 1,350 (1,300) pence - 'buy'

----------

Goldman Sachs cuts Mondi price target to 800 (910) pence - 'neutral'

----------

FTSE 250

----------

Deutsche Bank cuts Telecom Plus to 'hold' (buy) - price target 1,300 (2,000) pence

----------

Kepler Cheuvreux starts Primary Health Properties with 'buy' - price target 120 pence

----------

Goldman Sachs cuts Dr Martens price target to 71 (76) pence - 'neutral'

----------

Jefferies cuts Paragon Banking price target to 1,000 (1,060) pence - 'buy'

----------

Jefferies cuts OSB price target to 700 (780) pence - 'buy'

----------

SMALL CAP

----------

UBS cuts Fermi to 'neutral' (buy) - price target 6 (8) USD

----------

Berenberg raises Synthomer price target to 100 (60) pence - 'hold'

----------

Berenberg cuts CLS price target to 58 (80) pence - 'buy'

----------

Comments and questions to newsroom@alliancenews.com

Copyright 2026 Alliance News Ltd. All Rights Reserved.